HCV-IN-47
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
HCV-IN-47 (Compound (R) -1) shows anti-hepatitis C virus (HCV) activity with an EC50 value of 0.032 μM. HCV-IN-47 is promising for research of hepatitis C virus pathogenesis, and host-virus interaction[1].
300543-56-0
12352005
H302, H315, H319, H335
HCV
Anti-infection
COVID-19-anti-virus
Infection
98.50
ClC(C=C1)=CC=C1[C@H](N2CCNCC2)C3=CC=CC=C3
C17H19ClN2
286.80
H302, H315, H319, H335
[1]He S, et al. Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection. J Med Chem. 2016 Feb 11;59 (3) :841-53.
Room Temperature
4°C (Powder, protect from light)
http://file.medchemexpress.com/batch_PDF/HY-W103964/HCV-IN-47-SDS-MedChemExpress.pdf
Reference compound1
No Development Reported
Beschrijving
HCV-IN-47 (Compound (R) -1) shows anti-hepatitis C virus (HCV) activity with an EC50 value of 0.032 μM. HCV-IN-47 is promising for research of hepatitis C virus
Specificaties
Recent bekeken producten
Rat IgG Lyophilized
B2013903
25 mg
Fluorescent Nanodiamond in DI water, < 1ppm NV
NDNV20nmMd10ml
10 mL
Fluorescent Nanodiamond in DI water, ~3ppm NV
NDNV70nmHi10ml
10 mL
Ligation Buffer
LB001
1.4 mL
BioCoupler® x 12
BC12
12 Each
Recombinant Common timothy PHLPIV/Phl p 4 Protein, N-His
YZZ03001
100 μg
NP (4-hydroxy-3-nitrophenylacetate)
NP-BSA-03Low – 10 mg
10 mg
NP (4-hydroxy-3-nitrophenylacetate)
NP-BSA-03High – 10 mg
10 mg
Recent gezochte producten
Rabbit IgG Lyophilized
B2014183
50 mg
Goat IgG Lyophilized
B2013964
50 mg
Rat IgG Lyophilized
B2013903
25 mg
Rat IgG (Lyophilized Powder, ≥95%)
A7052-10mg
10 mg
Rat IgG (Lyophilized Powder, ≥95%)
A7052-2mg
2 mg
Rat IgG (Lyophilized Powder, ≥95%)
A7052-50mg
50 mg
Goat IgG (Lyophilized Powder, ≥95%)
A7054-10mg
10 mg
Goat IgG (Lyophilized Powder, ≥95%)
A7054-2mg
2 mg